Management explicitly guided for market share loss in their fastest growing segment, yet the math still prints money.
Thesis: Teradyne is executing a textbook mix shift from low-margin cyclical mobile testing to high-margin structural AI infrastructure. The street is obsessing over 'share loss' in HBM (from 50% to ~40%) while missing that the pie grew 5x ($100M to $500M). The complex packaging (CoWoS/HBM) bottleneck is a test intensity multiplier. They are not waiting for the cycle; they are forcing margin expansion via complexity.
Verdict: LONG — Conviction: HIGH
Catalyst: Q2 earnings confirming the 'hundreds of testers' for VIPs (hyperscalers) translating to revenue and Q4 gross margins hitting the 60% model.
Key Risk: HBM revenue is 'significantly over-indexed' to one customer (likely SK Hynix). If Samsung/Micron gain share with internal/competitor test tools, TER misses the volume ramp.
The Tell: When asked about HBM share, Smith didn't dodge: 'Our share is probably going to float down... The entire world is significantly over-indexed to one supplier.' He admitted the concentration risk and share dilution in the same breath, signaling supreme confidence that the TAM expansion ($100M -> $500M) makes the specific share percentage irrelevant.
Friction Level: MODERATE_FRICTION — Bears see peak HBM share and cyclical mobile weakness; Bulls see structural AI test intensity exploding TAM regardless of share drift.
Report not found
The report data is no longer available. Please return to the archive.